A new nano-optical bioimaging technology in development at PNNL enables researchers to watch climate-bellwether microbes exchange metabolites and other essential signals.
A multi-omics analysis provides the framework for gaining insights into the structure and function of microbial communities across multiple habitats on a planetary scale
Gosline works to develop computational algorithms that are uniquely targeted for rare disease work by doing foundational research in model system development. This work can be expanded to all model systems in human disease.
Data-driven autonomous technology to rapidly design and deliver antiviral interventions targeting SARS-CoV-2 to reduce drug discovery timeline and advance bio preparedness capabilities.
PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.
The Joint Appointment program at PNNL is one of the most diverse among other U.S. national laboratories, involving nearly 60 universities and research institutions in the United States and abroad.
New research findings published in Science Advances (November 2022), help explain the progression of Alzheimer-related dementia in each patient. The findings outline a biological classification system that predicts disease severity.
Advancing the science of radiation, especially among students at minority-serving institutions, is the goal of one of the Department of Energy’s newest consortia.
Two PNNL interns are behind recent innovation in real-time testing and continuous monitoring for pH and the concentration of chemicals of interest in chemical solutions; outcomes have applicability not only to nuclear, but to industries.
PNNL paper in Nuclear Technology journal unveils modeling possibilities for TRISO used fuel, implications for reactor planning, and resulting carbon-free nuclear energy.
